The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges.
CNS Spectrums December 1, 2024 Mauro Scala, Chiara Fabbri, Paolo Fusar‐poli et al. 8 citations
The revival of psilocybin in psychopharmacological research heralds a potential paradigm shift for treating mood and anxiety disorders, and other psychiatric conditions beyond the psychotic spectrum. This critical review evaluates current evidence on psilocybin's efficacy, juxtaposing potential benefits with the practical aspects of psychedelic-assisted psychotherapy (PAP) and the...